A-SPINE Asia Co., Ltd.

6758 · TWO · Healthcare / Medical Devices

29.50TWD+0.05 (+0.17%)

Price History

Full chart

Market Stats

Previous Close29.45

Open29.45

Day Range29.45 – 29.50

52-Week Range26.56 – 40.42

Volume3.00K

Market Cap414.91M

P/E (TTM)44.00

Forward P/E0.00

EPS0.70

Dividend Yield3.25%

50-Day Avg29.66

200-Day Avg33.99

About

A-SPINE Asia Co., Ltd., a medical device company, engages in the research, development, manufacture, and marketing of spinal implants and instruments in Taiwan, China, the Philippines, Australia, New Zealand, Iran, Vietnam, Indonesia, Spain, Trinidad, and Sri Lanka. The company offers spinal fixation systems, such as cervical anterior fixation, and thoracic and lumbar fixation systems; interbody fixation systems, including ACDF cages, PLIF/TLIF cages, and ALIF cages; balloon kyphoplasty products; and vertebral body replacement products. It sells imported orthopedic medical devices. A-SPINE Asia Co., Ltd.was founded in 2001 and is based in New Taipei City, Taiwan.

Company Details

SectorHealthcare
IndustryMedical Devices
HeadquartersNo. 80, Chenggong Road, New Taipei City, Taiwan, 234, Taiwan
Websitehttps://www.aspine.com.tw

Financials

Income Statement

Currency: TWD	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	339.86M	412.09M	400.19M	431.00M	369.97M	309.67M	330.16M	391.26M	404.95M	448.80M
Growth (%)	-	+21.25%	-2.89%	+7.70%	-14.16%	-16.30%	+6.62%	+18.51%	+3.50%	+10.83%
Cost of Revenue	74.42M	90.48M	86.56M	105.13M	82.69M	74.31M	99.88M	99.02M	100.03M	116.39M
Gross Profit	265.43M	321.61M	313.63M	325.87M	287.28M	235.36M	230.27M	292.24M	304.92M	332.40M
Gross Margin	78.10%	78.04%	78.37%	75.61%	77.65%	76.01%	69.75%	74.69%	75.30%	74.07%
Operating Expense	214.07M	249.10M	250.89M	253.80M	254.26M	214.48M	222.54M	281.14M	297.12M	313.96M
Operating Income	51.37M	72.51M	62.74M	72.07M	33.02M	20.88M	7.73M	11.10M	7.80M	18.44M
Operating Margin	15.11%	17.60%	15.68%	16.72%	8.93%	6.74%	2.34%	2.84%	1.93%	4.11%
EBITDA	57.14M	80.18M	73.64M	81.41M	48.92M	38.43M	27.86M	29.78M	26.87M	34.50M
EBITDA Margin	16.81%	19.46%	18.40%	18.89%	13.22%	12.41%	8.44%	7.61%	6.64%	7.69%
Net Income	43.68M	59.43M	50.10M	70.73M	30.39M	17.74M	8.01M	9.21M	8.41M	15.08M
Net Income Margin	12.85%	14.42%	12.52%	16.41%	8.21%	5.73%	2.43%	2.35%	2.08%	3.36%
R&D	25.43M	21.18M	25.80M	29.10M	25.99M	22.23M	20.40M	26.00M	24.92M	31.12M
R&D as % of Total Revenue	7.48%	5.14%	6.45%	6.75%	7.02%	7.18%	6.18%	6.65%	6.15%	6.93%
Interest Expense	23.00K	66.00K	1.43M	1.65M	1.51M	1.33M	1.69M	2.55M	3.00M	2.98M
Interest Expense % of Total Revenue	0.01%	0.02%	0.36%	0.38%	0.41%	0.43%	0.51%	0.65%	0.74%	0.66%

Balance Sheet

Currency: TWD	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	-	-	-	-	542.26M	499.61M	511.01M	514.61M	506.51M	519.53M
Total Liabilities	-	-	-	777.00K	243.75M	210.44M	233.93M	240.61M	235.72M	245.13M
Total Equity	-	-	-	-	298.51M	289.18M	277.08M	274.00M	270.79M	274.40M
Cash	-	-	-	-	65.16M	65.04M	82.46M	54.27M	47.99M	56.60M
Total Debt	-	-	-	-	125.61M	118.71M	147.38M	136.28M	132.89M	-
Net Debt	-	-	-	-	60.45M	53.67M	64.92M	82.00M	84.90M	71.83M

Cash Flow

Currency: TWD	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	42.03M	33.21M	34.98M	18.27M	3.96M	17.54M	29.75M
Investing Cash Flow	-19.18M	-5.62M	48.00K	-4.85M	-7.84M	-3.98M	-
Financing Cash Flow	-33.78M	-24.69M	-35.15M	4.00M	-24.31M	-19.84M	-
Capital Expenditure	18.73M	6.10M	2.95M	4.61M	3.47M	4.50M	1.57M
Free Cash Flow	23.29M	27.11M	32.03M	13.66M	487.00K	13.04M	28.18M
Dividends Paid	32.33M	33.68M	26.94M	20.21M	13.47M	13.47M	13.47M
FCF to OCF	55.42%	81.62%	91.58%	74.78%	12.31%	74.32%	94.71%
Dividend Paid to FCF	138.80%	124.24%	84.12%	147.90%	2766.12%	103.34%	47.81%

Key Statistics & Ratios

Market Cap414.91M

Enterprise Value502.56M

Trailing P/E44.00

Forward P/E0.00

Price / Sales0.89

Price / Book1.53

EPS0.70

Revenue (TTM)0

Gross Profit (TTM)0

Profit Margin0.00%

Operating Margin0.00%

Return on Equity0.00%

Return on Assets0.00%

Shares Outstanding13.47M

Shares Float0

Dividend Yield3.25%

Dividend Rate1.00

Payout Ratio143.49%

Dividends

20261×

1.00Aug 4, 2026

20251×

1.00Jul 30, 2025

20241×

1.00Jul 30, 2024

20231×

1.00Jul 25, 2023

20221×

1.50Jul 26, 2022

20211×

2.00Aug 23, 2021

20201×

2.50Aug 13, 2020